Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Global Transdermal Drug Delivery Market 2017-2023 - Trends and Drivers, Restraints, and Opportunities - ResearchAndMarkets.com

Research and Markets
Posted on: 31 Jan 18

The "Global Transdermal Drug Delivery Market Trends and Drivers, Restraints, and Opportunities 2017-2023" report has been added to ResearchAndMarkets.com's offering.

The Global Transdermal Drug Delivery Market is estimated to witness a CAGR of 9.5% during the forecast period 2017-2023.

The regions covered in the report are North America, Europe, Asia Pacific, and Rest of the World (RoW). In the North American region, the US is set to be the leading country. Europe is set to be the second leading region and holds more than 26.3% of the market share in 2016. In Asia Pacific, India, Japan, and China is one of the most attractive countries for the players and holds huge business opportunities. RoW is set to be an emerging market in the next 5-6 years.

Based on the technology types, the market is segmented into Passive and Active transdermal technology. At present the market is dominated by passive technology. However, the advent of novel technology for enhancing the permeation of drugs through the skin is driving the market growth. Hence the highest growth rate is expected to be witnessed in the active transdermal drug delivery technology.

The product types covered in the report are Patches and Gels. Transdermal Patches are likely to continue to dominate the market by 2023. Stringent regulatory approval and high cost of the transdermal drug delivery systems represents as the major challenge the growth of transdermal drug delivery market. The market is expected to be on a positive year on year growth rate, as the increase in chronic diseases prevalence and expanded application areas of the technology is expected during the forecast period.

3M, Boehringer Ingelheim, Johnson and Johnson, Mylan N.V., Novartis, and GlaxoSmithKline, are the key players in the market. Echo Therapeutics Inc., Noven Pharmaceuticals, Transdermal Corp, Actavis, Bayer, and Corium International, are the other key players in the market.

Key Topics Covered:

1 Industry Outlook

2 Report Outline

3 Market Snapshot

4 Market Outlook

5 Market Characteristics

6 Types: Market Size and Analysis

7 Technology: Market Size and Analysis

8 Drug Types: Market Size and Analysis

9 Regions: Market Size and Analysis

10 Competitive Landscape

11 Vendor Profiles

  • 3M
  • Actavis, Inc.
  • Bayer AG
  • Boehringer Ingelheim GmbH
  • Corium International, Inc.
  • Echo Therapeutics, Inc.
  • GlaxoSmithKline plc
  • Johnson & Johnson (Janssen Pharmaceuticals Inc.)
  • Mylan N.V.
  • Novartis AG
  • Noven Pharmaceuticals, Inc.
  • Transdermal Corp.

For more information about this report visit https://www.researchandmarkets.com/research/94256c/global?w=4

View source version on businesswire.com: http://www.businesswire.com/news/home/20180131005615/en/

Business Wire
www.businesswire.com

Last updated on: 31/01/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.